New formula could make transplant pregnancies safer
NCT ID NCT07422012
First seen Feb 21, 2026 · Last updated May 16, 2026 · Updated 8 times
Summary
This study aims to create a formula that adjusts tacrolimus blood levels in pregnant women who have had a uterus transplant. Pregnancy changes how the body processes the drug, so current tests may not show the true active amount. Researchers will study 55 participants to develop a more accurate dosing method.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNBOUND TACROLIMUS IN PREGNANT UTERUS TRANSPLANT RECIPIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor University Center of Dallas
Dallas, Texas, 75246, United States
Conditions
Explore the condition pages connected to this study.